Eli Lilly attempts to block Sun Pharma's generic Strattera

09/25/2007 | Business Standard (India)

Eli Lilly & Co. has filed a patent infringement suit against Sun Pharmaceutical Industries, which seeks to produce and sell a generic version of Lilly's attention deficit hyperactivity disorder drug Strattera. In a complaint filed Sept. 20, Eli Lilly said the company would be "irreparably harmed" by the FDA's approval of Sun's request.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care